Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe …
Dupixent® (dupilumab) is now approved in India for the treatment of adults with moderate-to-severe …
Empathy in Action: CARS24 Introduces Industry First Compassion Policy October 7, 2024 – Mumbai, I…
Venus , Remedies , European , Market , Global , Renewal , Oncology , Certification , Across , Europ…
Titan Company Ltd. and Himmotthan Empower Women & Communities in Uttarakhand, Offset 126 Millio…
Monkeypox is a viral disease caused by the monkeypox virus, which belongs to the Orthopoxvirus genu…
Campaign , Sexual , Children , Child , They , Will , Arpan , Protectedbypocso , Abuse , Offenders ,…
JICA extends ODA loan of INR 4,649 crores for Delhi Mass Rapid Transport System Project (Phase 4 A…
Job Category :: Non Government Organization (NGO) Women bear almost all responsibility for meeting …
3.85 lakh Bihar teachers will be transferred and posted in December and January The Bihar gover…
Grundfosbrings together industry experts forthe ‘10thAnnual Sustainable Water Management Conclave’ …
T HE E CONOMIC T IMES Tue, Jul 03, 2018 | 06:31 AM IS…